These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4017161)

  • 1. Effects of amino acids on the transport and cytotoxicity of melphalan by human bone marrow cells and human tumor cells.
    Dufour M; Panasci LC; St Germain J; Boulet L
    Cancer Chemother Pharmacol; 1985; 15(2):125-31. PubMed ID: 4017161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity as an indicator for transport mechanism: evidence that melphalan is transported by two leucine-preferring carrier systems in the L1210 murine leukemia cell.
    Vistica DT
    Biochim Biophys Acta; 1979 Jan; 550(2):309-17. PubMed ID: 569503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity as an indicator for transport mechanism: evidence that murine bone marrow progenitor cells lack a high-affinity leucine carrier that transports melphalan in murine L1210 leukemia cells.
    Vistica DT
    Blood; 1980 Sep; 56(3):427-9. PubMed ID: 7407411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid conferred protection against melphalan: comparison of amino acids which reduce melphalan toxicity to murine bone marrow precursor cells (CFU-C) and murine L1210 leukemia cells.
    Vistica DT; Rabon A; Rabinovitz M
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):171-83. PubMed ID: 441510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple transport pathways for L1210 cells: uptake of PTT.119, a bifunctional alkylator with carrier amino acids.
    Yagi MJ; Scanlon KJ; Chin SE; Holland JF; Bekesi JG
    Chemotherapy; 1988; 34(3):235-47. PubMed ID: 3416661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro comparative studies of the myelotoxicity and antitumor activity of 6-[bis-(2-chloroethyl)-amino]-6-deoxy-D-glucose versus melphalan utilizing the CFU-C and HTSCA assays.
    Lazarus P; Dufour M; Isabel G; Panasci LC
    Cancer Chemother Pharmacol; 1986; 16(2):148-52. PubMed ID: 3948300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil potentiation of melphalan cytotoxicity and cellular uptake in murine fibrosarcoma and bone marrow.
    Robinson BA; Clutterbuck RD; Millar JL; McElwain TJ
    Br J Cancer; 1985 Dec; 52(6):813-22. PubMed ID: 4074636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of 2-aminobicyclo[3.2.1]octane-2-carboxylic acid with the amino acid transport systems of the sarcoma 37 murine ascites tumor cell.
    Elliott MS; Matthews RH; Minton JP; Zand R
    Biochemistry; 1981 Sep; 20(18):5105-8. PubMed ID: 7295668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acid-conferred protection against melphalan--characterization of melphalan transport and correlation of uptake with cytotoxicity in cultured L1210 murine leukemia cells.
    Vistica DT; Toal JN; Rabinovitz M
    Biochem Pharmacol; 1978; 27(24):2865-70. PubMed ID: 736979
    [No Abstract]   [Full Text] [Related]  

  • 10. Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in a human glioma cell line: comparison with [3H]methyl]-L-methionine.
    Langen KJ; Mühlensiepen H; Holschbach M; Hautzel H; Jansen P; Coenen HH
    J Nucl Med; 2000 Jul; 41(7):1250-5. PubMed ID: 10914918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased melphalan accumulation in a human breast cancer cell line selected for resistance to melphalan.
    Moscow JA; Swanson CA; Cowan KH
    Br J Cancer; 1993 Oct; 68(4):732-7. PubMed ID: 8398701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid-conferred resistance to melphalan. I. Structure-activity relationship in cultured murine L1210 leukemia cells.
    Vistica DT; Toal JN; Rabinovitz M
    Cancer Treat Rep; 1976 Sep; 60(9):1363-7. PubMed ID: 1016969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transport of the aromatic amino acids into isolated rat liver cells. Properties of uptake by two distinct systems.
    Salter M; Knowles RG; Pogson CI
    Biochem J; 1986 Jan; 233(2):499-506. PubMed ID: 3954748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active carrier-mediated transport of melphalan by two separate amino acid transport systems in LPC-1 plasmacytoma cells in vitro.
    Goldenberg GJ; Lam HY; Begleiter A
    J Biol Chem; 1979 Feb; 254(4):1057-64. PubMed ID: 762115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of melphalan by human ovarian carcinoma cells and its relationship to the amino acid content of ascitic fluid.
    Vistica DT; Von Hoff DD; Torain B
    Cancer Treat Rep; 1981; 65(1-2):157-61. PubMed ID: 7226165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid conferred protection against melphalan: interference with leucine protection of melphalan cytotoxicity by the basic amino acids in cultured murine L1210 leukemia cells.
    Vistica DT; Toal JN; Rabinovitz M
    Mol Pharmacol; 1978 Nov; 14(6):1136-42. PubMed ID: 732811
    [No Abstract]   [Full Text] [Related]  

  • 17. Further studies on amino acid transport in murine P388 leukemia cells in vitro. Presence of system y+.
    Lazarus P; Panasci LC
    Biochim Biophys Acta; 1987 Apr; 898(2):154-8. PubMed ID: 3103685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the transport of chlorozotocin and CCNU in L1210 leukemia and murine bone marrow cells in vitro.
    Lazarus P; Germina JS; Dufour M; Palmer G; Wallace D; Panasci LC
    Cancer Chemother Pharmacol; 1983; 11(3):159-61. PubMed ID: 6227421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport, metabolism, and DNA interaction of melphalan in lymphocytes from patients with chronic lymphocytic leukemia.
    Panasci L; Henderson D; Torres-Garcia SJ; Skalski V; Caplan S; Hutchinson M
    Cancer Res; 1988 Apr; 48(7):1972-6. PubMed ID: 3349471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
    Pu Q; Bianchi P; Bezwoda WR
    Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.